Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A T Goldberg

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The Annals of Thoracic Surgery|April 6, 2000
Endothelin receptor pathway in human left ventricular myocytes: relation to contractilityA T Goldberg, B R Bond, R Mukherjee, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|January 11, 2001
Bradykinin degradation and relation to myocyte contractilityR S Krombach, J H McElmuray, D M Gay, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 24, 2000
Temporal endothelin dynamics of the myocardial interstitium and systemic circulation in cardiopulmonary bypassC A Walker, S C Baicu, A T Goldberg, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 2, 2001
Endothelin receptor subtype A blockade selectively reduces pulmonary pressure after cardiopulmonary bypassC Joffs, C A Walker, J W Hendrick, et al.
Circulation|October 18, 2000
A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failureF G Spinale, M L Coker, L J Heung, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|March 22, 2002
Myocardial bradykinin following acute angiotensin-converting enzyme inhibition, AT1 receptor blockade, or combined inhibition in congestive heart failureM M Multani, R S Krombach, A T Goldberg, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 28, 2000
Selective vasopressin, angiotensin II, or dual receptor blockade with developing congestive heart failureM J Clair, M K King, A T Goldberg, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The Annals of Thoracic Surgery|April 6, 2000
Endothelin receptor pathway in human left ventricular myocytes: relation to contractilityA T Goldberg, B R Bond, R Mukherjee, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|January 11, 2001
Bradykinin degradation and relation to myocyte contractilityR S Krombach, J H McElmuray, D M Gay, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 24, 2000
Temporal endothelin dynamics of the myocardial interstitium and systemic circulation in cardiopulmonary bypassC A Walker, S C Baicu, A T Goldberg, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 2, 2001
Endothelin receptor subtype A blockade selectively reduces pulmonary pressure after cardiopulmonary bypassC Joffs, C A Walker, J W Hendrick, et al.
Circulation|October 18, 2000
A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failureF G Spinale, M L Coker, L J Heung, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|March 22, 2002
Myocardial bradykinin following acute angiotensin-converting enzyme inhibition, AT1 receptor blockade, or combined inhibition in congestive heart failureM M Multani, R S Krombach, A T Goldberg, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 28, 2000
Selective vasopressin, angiotensin II, or dual receptor blockade with developing congestive heart failureM J Clair, M K King, A T Goldberg, et al.
Pageof 2